These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention. Brogard JM; Comte F; Spach MO Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194 [No Abstract] [Full Text] [Related]
3. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity. Giuliano RA; Verpooten GA; De Broe ME Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968 [No Abstract] [Full Text] [Related]
4. Data collection techniques for aminoglycoside dosing programs. Canton M Am J Hosp Pharm; 1986 Oct; 43(10):2386, 2390. PubMed ID: 3788987 [No Abstract] [Full Text] [Related]
5. [Aminoglycosides--is the once-daily dosage a recommendation made after several studies?]. Stahl M Lakartidningen; 1991 Sep; 88(36):2858-9. PubMed ID: 1895835 [No Abstract] [Full Text] [Related]
6. Nomograms for drug use in renal disease. Chennavasin P; Brater DC Clin Pharmacokinet; 1981; 6(3):193-214. PubMed ID: 7016384 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobials in renal impairment. Lefrock JL; Smith BR Am Fam Physician; 1982 Jun; 25(6):201-5. PubMed ID: 7081009 [No Abstract] [Full Text] [Related]
10. [Antibiotics and chemotherapy--from research to practice. VI. Remarks addressed to practitioners concerning aminoglucoside characteristics]. Pilloud M Schweiz Arch Tierheilkd; 1983 May; 125(5):301-15. PubMed ID: 6612284 [No Abstract] [Full Text] [Related]
11. The penetration of antibiotics into peritoneal fluid. Gerding DN; Hall WH Bull N Y Acad Med; 1975 Oct; 51(9):1016-9. PubMed ID: 1058726 [No Abstract] [Full Text] [Related]
12. [Clinical studies of intravenous drip infusion of micronomicin. 1. Pharmacokinetics (Part 2). Intravenous Micronomicin Research Group]. Watanabe M; Saito I; Mitsuhashi S; Koyama M; Kawaguchi Y Jpn J Antibiot; 1985 Apr; 38(4):1086-92. PubMed ID: 4032720 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of tobramycin. Horikoshi N; Valdivieso M; Bodey GP Am J Med Sci; 1973 Dec; 266(6):453-8. PubMed ID: 4774079 [No Abstract] [Full Text] [Related]
14. A calculator program for adjusting aminoglycoside regimens that accounts for tissue accumulation in children and adolescents. Loertscher MV Drug Intell Clin Pharm; 1982; 16(7-8):563-8. PubMed ID: 7105975 [TBL] [Abstract][Full Text] [Related]
15. Tritiation of tylosin and metabolic study in the rat. Wal JM; Bories GF J Antibiot (Tokyo); 1973 Nov; 26(11):687-91. PubMed ID: 4792117 [No Abstract] [Full Text] [Related]
16. Modification of drug therapy in chronic dialysis patients. Cutler RE; Christopher TG; Forrey AW; Blair AD Kidney Int Suppl; 1975 Jan; (2):16-22. PubMed ID: 1057676 [No Abstract] [Full Text] [Related]
17. [Protective effect of fosfomycin against renal accumulation of aminoglycoside antibiotics]. Fujita K; Fujita HM; Aso Y Jpn J Antibiot; 1983 Dec; 36(12):3392-4. PubMed ID: 6674549 [TBL] [Abstract][Full Text] [Related]
18. [Positioning of various anti-bacterial agents and their appropriate use in the era of multiple bacterial drug resistance. 6. Aminoglycosides]. Sakamoto M; Sato F; Shiba K Nihon Naika Gakkai Zasshi; 2003 Nov; 92(11):2136-40. PubMed ID: 14679805 [No Abstract] [Full Text] [Related]
19. Effect of aminoglycosides on the pathogenic characteristics of microbiology. Xu Z; Xu X; Qi D; Yang L; Li B; Li L; Li X; Chen D Microb Pathog; 2017 Dec; 113():357-364. PubMed ID: 28867624 [TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics in serum and sputum of sagamicin administered intramuscularly to patients. Fraschini F; Scaglione F; Scarpazza G; Marchi M; Braga PC Chemotherapy; 1987; 33(2):85-92. PubMed ID: 3568801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]